Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited

GZPHF · OTC
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income$111$0$1,821$0
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC$0-$2,608$0$0
Other Non-Cash$126$3,108-$5,719$0
Operating Cash Flow$237$500-$3,897$0
Investing Activities
PP&E Inv.-$59-$271-$226-$316
Net Acquisitions$3$0$0$0
Inv. Purchases-$513-$4,722-$1,240-$2,421
Inv. Sales/Matur.$703$1,004$725$1,012
Other Inv. Act.$0$5$2$1
Investing Cash Flow$134-$3,984-$739-$1,724
Financing Activities
Debt Repay.-$123$1,481$1,174-$756
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0-$656-$84-$769
Other Fin. Act.-$4$67-$64-$69
Financing Cash Flow-$128$893$1,026-$1,594
Forex Effect$51-$1$6$2
Net Chg. in Cash$295-$2,592-$3,604$878
Supplemental Information
Beg. Cash$1,629$12,699$16,303$15,425
End Cash$1,925$10,107$12,699$16,303
Free Cash Flow$179$229-$4,124$3,878
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (GZPHF) Financial Statements & Key Stats | AlphaPilot